Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
Alberto EsquenaziGanesh BavikatteDaniel S BandariWolfgang H JostMichael C MuninSimon Fuk Tan TangJoan LargentAubrey Manack AdamsAleksej ZuzekGerard E FranciscoPublished in: PM & R : the journal of injury, function, and rehabilitation (2021)
ASPIRE provides long-term observational data on the treatment of lower limb spasticity with onabotulinumtoxinA. Real-world data from this primary analysis can help to guide the clinical use of onabotulinumtoxinA to improve spasticity management.